...consider raising another round in about 18 months to support a broader expansion. Another company, Biometheus LLC...
...website has been taken down, and an inquiry to its former CEO went unreturned (see "Biometheus...

...companies to exclude these patients up front and cut trial sizes in half. Last week, Biometheus...
...gene. The partners are finalizing the terms of an exclusive license agreement for the marker. Biometheus...
...Biometheus LLC , Boston, Mass. U.S. Food and Drug Administration (FDA) , Silver Spring, Md. Sidebars Biometheus LLC...

...Newco Biometheus emerged from stealth mode and announced an exclusive option from Beth Israel Deaconess Medical...
...option from Beth Israel Deaconess Medical Center to IP covering technology to detect placebo responders. Biometheus...
...to license the test to third-parties to screen patients for the polymorphism for clinical trials. Biometheus...

...Newco Biometheus LLC (Cambridge, Mass.) emerged from stealth mode on Monday and announced an exclusive option from...
...option from Beth Israel Deaconess Medical Center to IP covering technology to detect placebo responders. Biometheus...
...license the test to third parties to screen patients for the polymorphism for clinical trials. Biometheus...